Dana-Farber Cancer Institute /ID# 207728

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Cancer, Leukemia, T-cell Prolymphocytic Leukemia (T-PLL)

Studies at this site

• A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic Leukemia — Completed